Article

Thioredoxin reductase, an emerging target for anticancer metallodrugs. Enzyme inhibition by cytotoxic gold(III) compounds studied with combined mass spectrometry and biochemical assays.
Gabbiani, C., Mastrobuoni, G., Sorrentino, F., Dani, B., Rigobello, M.P., Bindoli, A., Cinellu, M.A., Pieraccini, G., Messori, L. and Casini, A.
MedChemComm 2 (1): 50-54. January 2011